Cargando…

Depletion of T cells via Inducible Caspase 9 Increases Safety of Adoptive T-Cell Therapy Against Chronic Hepatitis B

T-cell therapy with T cells that are re-directed to hepatitis B virus (HBV)-infected cells by virus-specific receptors is a promising therapeutic approach for treatment of chronic hepatitis B and HBV-associated cancer. Due to the high number of target cells, however, side effects such as cytokine re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klopp, Alexandre, Schreiber, Sophia, Kosinska, Anna D., Pulé, Martin, Protzer, Ulrike, Wisskirchen, Karin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527178/ https://www.ncbi.nlm.nih.gov/pubmed/34691041 http://dx.doi.org/10.3389/fimmu.2021.734246

Ejemplares similares

Activation of distinct antiviral T-cell immunity: A comparison of bi- and trispecific T-cell engager antibodies with a chimeric antigen receptor targeting HBV envelope proteins
por: Debelec-Butuner, Bilge, et al.
Publicado: (2022)

Secreted Interferon-Inducible Factors Restrict Hepatitis B and C Virus Entry In Vitro
por: Xia, Yuchen, et al.
Publicado: (2017)

Hepatitis-D Virus Infection Is Not Impaired by Innate Immunity but Increases Cytotoxic T-Cell Activity
por: Altstetter, Sebastian Maximilian, et al.
Publicado: (2021)

Characterization of a library of 20 HBV-specific MHC class II-restricted T cell receptors
por: Schreiber, Sophia, et al.
Publicado: (2021)

New pharmacological strategies to fight enveloped viruses
por: Wisskirchen, Karin, et al.
Publicado: (2014)

Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use
por: Wisskirchen, Karin, et al.
Publicado: (2017)

Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein
por: Sautto, Giuseppe A, et al.
Publicado: (2016)

Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell Malignancies
por: Guercio, Marika, et al.
Publicado: (2021)

PD-L1 Silencing in Liver Using siRNAs Enhances Efficacy of Therapeutic Vaccination for Chronic Hepatitis B
por: Bunse, Till, et al.
Publicado: (2022)

Improving Therapeutic Vaccination against Hepatitis B—Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection
por: Knolle, Percy A., et al.
Publicado: (2021)

Adoptive T-cell therapy to treat liver cancer: Is the liver microenvironment key?
por: Willimsky, Gerald, et al.
Publicado: (2013)

Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal
por: Bianchi, Valentina, et al.
Publicado: (2020)

Hepatitis B Vaccine Non-Responders Show Higher Frequencies of CD24(high)CD38(high) Regulatory B Cells and Lower Levels of IL-10 Expression Compared to Responders
por: Körber, Nina, et al.
Publicado: (2021)

Immune escape pathways from the HBV core(18-27) CD8 T cell response are driven by individual HLA class I alleles
por: Walker, Andreas, et al.
Publicado: (2022)

Adoptive Cell Transfer of Regulatory T Cells Exacerbates Hepatic Steatosis in High-Fat High-Fructose Diet-Fed Mice
por: Van Herck, Mikhaïl A., et al.
Publicado: (2020)

The Evolution of T Cell Depleted Haploidentical Transplantation
por: Aversa, Franco, et al.
Publicado: (2019)

A Rapamycin-Activated Caspase 9-Based Suicide Gene
por: Stavrou, Maria, et al.
Publicado: (2018)

Evolutionarily Ancient Caspase-9 Sensitizes Immune Effector Coelomocytes to Cadmium-Induced Cell Death in the Sea Cucumber, Holothuria leucospilota
por: Li, Xiaomin, et al.
Publicado: (2022)

Editorial: Targeting the Immune System to Treat Hepatitis B Virus Infection
por: Meng, Zhongji, et al.
Publicado: (2022)

Immunogenicity and Antiviral Response of Therapeutic Hepatitis B Vaccination in a Mouse Model of HBeAg-Negative, Persistent HBV Infection
por: Kosinska, Anna D., et al.
Publicado: (2021)

Depletion of Specific Cell Populations by Complement Depletion
por: Dittel, Bonnie N.
Publicado: (2010)

PD-1-Mediated PI3K/Akt/mTOR, Caspase 9/Caspase 3 and ERK Pathways Are Involved in Regulating the Apoptosis and Proliferation of CD4(+) and CD8(+) T Cells During BVDV Infection in vitro
por: Liu, Yu, et al.
Publicado: (2020)

Combining a CD20 Chimeric Antigen Receptor and an Inducible Caspase 9 Suicide Switch to Improve the Efficacy and Safety of T Cell Adoptive Immunotherapy for Lymphoma
por: Budde, Lihua E., et al.
Publicado: (2013)

Antibody-mediated cell depletion therapies in multiple sclerosis
por: Mariottini, Alice, et al.
Publicado: (2022)

Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome
por: Caldarale, Francesca, et al.
Publicado: (2021)

Role of T Cell Receptor Affinity in the Efficacy and Specificity of Adoptive T Cell Therapies
por: Stone, Jennifer D., et al.
Publicado: (2013)

Adoptive T Cell Therapy Following Haploidentical Hematopoietic Stem Cell Transplantation
por: Zhang, Ping, et al.
Publicado: (2019)

Adoptive Transfer of Regulatory Immune Cells in Organ Transplantation
por: Oberholtzer, Nathaniel, et al.
Publicado: (2021)

Editorial: Implementing Logic Gates in Adoptive Cell Therapy
por: Gross, Gideon, et al.
Publicado: (2022)

Adoptive B cell therapy for chronic viral infection
por: Chung, Young Rock, et al.
Publicado: (2022)

Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion
por: Rådestad, Emelie, et al.
Publicado: (2019)

Advances in Adoptive Cell Therapy Using Induced Pluripotent Stem Cell-Derived T Cells
por: Netsrithong, Ratchapong, et al.
Publicado: (2021)

The First Step in Adoptive Cell Immunotherapeutics: Assuring Cell Delivery via Glycoengineering
por: Sackstein, Robert
Publicado: (2019)

Adoptive T Cell Therapy Targeting CD1 and MR1
por: Guo, Tingxi, et al.
Publicado: (2015)

Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma
por: Weil, Sandra, et al.
Publicado: (2017)

Long-Lived Plasma Cells in Autoimmunity: Lessons from B-Cell Depleting Therapy
por: Mahévas, Matthieu, et al.
Publicado: (2013)

Splenic Dendritic Cells and Macrophages Drive B Cells to Adopt a Plasmablast Cell Fate
por: McNamara, Hayley A., et al.
Publicado: (2022)

Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy
por: Lei, Kewen, et al.
Publicado: (2021)

Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer
por: Cheng, Hongyan, et al.
Publicado: (2021)

Hepatitis B Virus Impairs TLR9 Expression and Function in Plasmacytoid Dendritic Cells
por: Vincent, Isabelle E., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_l2o2vsk3neg9u8onse4cbfaic5